J Korean Soc Endocrinol.  2005 Dec;20(6):535-542. 10.3803/jkes.2005.20.6.535.

Epidemiology and Biological Correlation Between Osteoporosis and Atherosclerosis

• Choi WH

• KMID: 1572431
• DOI: http://doi.org/10.3803/jkes.2005.20.6.535

Abstract

No Abstract available.

MeSH Terms

Atherosclerosis*
Epidemiology*
Osteoporosis*

Reference

1. Boukhris R, Becker KL. Calcification of the aorta and osteoporosis. A roentgenographic study. JAMA. 1972. 219:1307–1311.

2. Barengolts EI, Berman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int. 1998. 62:209–213.

3. Ouchi Y, Akishita M, deSouza AC, Nakamura T, Orimo H. Age-related loss of bone mass and aortic/ aortic valve calcification-reevaluation of recommended dietary allowance of calcium in the elderly. Ann NY Acad Sci. 1993. 676:297–307.

4. Hak AE, Pols HAP, van Hemert AM, Hofman A, Witteman JCM. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterios cler Thromb Vasc Biol. 2000. 20:1926–1931.

5. Hyman JB, Epstein FH. A study of the correlation between roentgenographic and post-mortem calcification of the aorta. Am Heart J. 1954. 48:540–543.

6. Genant HK, Engelke K, Fuerst T, Gluer CC, Grampp S, Harris ST, Jergas M, Lang T, Lu Y, Majumdar S, Mathur A, Takada M. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res. 1996. 11:707–730.

7. Whitehouse RW, Karantanas A, Adams JE. Ring EFG, editor. Discrepancies in spinal bone mass measured by QCT and DXA. Current research in osteoporosis and bone mineral measurement II. 1992. London and Bath: British Institute of Radiology;26.

8. Banks LM, Lees B, MacSweeney JE, Stevenson JC. Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women:links between osteoporosis and cardiovascular disease? EurJ Clin Invest. 1994. 24:813–817.

9. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004. 89:4246–4253.

10. Bostrom K, Demer LL. Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr. 2000. 10:151–158.

11. Rubin MR, Silverberg SJ. Vascular calcification and osteoporosis-the nature of the nexus. J Clin Endocrinol Metab. 2004. 89:4243–4245.

12. Speer MY, Giachelli CM. Regulation of cardiovascular calcification. Cardiovasc Pathol. 2004. 13:63–70.

13. Trion A, van der Laarse A. Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J. 2004. 147:808–814.

14. Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol. 2002. 31:737–741.

15. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens. 2002. 15:426–444.

16. Virchow R. Cellular pathology. As based upon physiological and pathological histology. Lecture XVI-Atheromatous affection of arteries. 1858. Nutr Rev. 1989. 47:23–25.

17. Witteman JC, Kannel WB, Wolf PA, Grobbee DE, Hofman A, D'Agostino RB, Cobb JC. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am J Cardiol. 1990. 66:1060–1064.

18. Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 2000. 283:2810–2815.

19. Wallin R, Wajih N, Greenwood GT, Sane DC. Arterial calcification: a review of mechanisms, animal models, and the prospects for therapy. Med Res Rev. 2001. 21:274–301.

20. Fitzpatrick LA, Turner RT, Ritman ER. Endochondral bone formation in the heart: a possible mechanism of coronary calcification. Endocrinology. 2003. 144:2214–2219.

21. Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A. 2003. 100:11201–11206.

22. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004. 286:E686–E696.

23. Whitfield JF. Osteogenic PTHs and vascular ossification-Is there a danger for osteoporotics? J Cell Biochem. 2005. 95:437–444.

24. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC. Medial calcinosis of Monckeberg: a review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977. 63:615–622.

25. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996. 16:978–983.

26. Niskanen L, Siitonen O, Suhonen M, Uusitupa MI. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care. 1994. 17:1252–1256.

27. Nelson RG, Gohdes DM, Everhart JE, Hartner JA, Zwemer FL, Pettitt DJ, Knowler WC. Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care. 1994. 17:1252–1256.

28. Roberts WC. The senile cardiac calcification syndrome. Am J Cardiol. 1986. 58:572–574.

29. Tenenbaum A. Coronary calcium and coronary disease: specificity is better than it seems. Circulation. 1996. 94:2995–2996.

30. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Circulation. 1996. 94:1175–1192.

31. Wong ND, Kouwabunpat D, Vo AN, et al. Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women. Am Heart J. 1994. 127:422–430.

32. Adler Y, Vaturi M, Herz I, Iakobishvili Z, Toaf J, Fink N, Battler A, Sagie A. Nonobstructive aortic valve calcification: a window to significant coronary artery disease. Atherosclerosis. 2002. 161:193–197.

33. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000. 343:611–617.

34. Tenenbaum A, Fisman EZ, Schwammenthal E, Adler Y, Shemesh J, Sherer Y, Motro M. Aortic valve calcification in hypertensive patients: prevalence, risk factors and association with transvalvular flow velocity. Int J Cardiol. 2004. 94:7–13.

35. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993. 91:1800–1809.

36. Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol. 2002. 31:737–741.

37. Lachman AS, Spray TL, Kerwin DM, Shugoll GI, Roberts WC. Medial calcinosis of Monckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am J Med. 1977. 63:615–622.

38. LINDBOM A. Arteriosclerosis and arterial thrombosis in the lower limb: a roentgenological study. Acta Radiol Suppl. 1950. 80:1–80.

39. Chen NX, Moe SM. Arterial calcification in diabetes. Curr Diab Rep. 2003. 3:28–32.

40. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. MSX2 promotes osteogenesis and supp resses adipogenic differentiation of multipotent mesen chymal progenitors. J Biol Chem. 2003. 278:45969–45977.

41. Karsenty G. Minireview: transcriptional control of ost eoblast differentiation. Endocrinology. 2001. 142:2731–2733.

42. Satokata I, Ma L, Ohshima H, Bei M, Woo I, Nishizawa K, Maeda T, Takano Y, Uchiyama M, Heaney S, Peters H, Tang Z, Maxson R, Maas R. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet. 2000. 24:391–395.

43. Towler DA, Bidder M, Latifi T, Coleman T, Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem. 1998. 273:30427–30434.

44. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994. 90:844–853.

45. Wallby L, Janerot-Sjoberg B, Steffensen T, Broqvist M. T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves. Heart. 2002. 88:348–351.

46. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001. 10:1522–1528.

47. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003. 107:2181–2184.

48. Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int Suppl. 2002. 82:73–80.

49. Johnson K, Goding J, Van Etten D, Sali A, Hu SI, Farley D, Krug H, Hessle L, Millan JL, Terkeltaub R. Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J Bone Miner Res. 2003. 18:994–1004.

50. Fiore S, Serhan CN. Formation of lipoxins and leukot rienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrop hage colony-stimulating factor-primed neutrophils. J Exp Med. 1990. 172:1451–1457.

51. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997. 17:680–687.

52. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000. 102:2636–2642.

53. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am. 2003. 85-A:Suppl 3. 59–66.

54. Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T, Inaba M, Nishizawa Y. Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control. Diabetologia. 2002. 45:1446–1448.

55. Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation. 2003. 108:472–478.

56. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol. 2000. 20:1926–1931.

58. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr, Forrester JS, Douglas PS, Faxon DP, Fisher JD, Gregoratos G, Hochman JS, Hutter AM Jr, Kaul S, Wolk MJ. Am College of Cardiology/Am Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000. 102:126–140.

59. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000. 343:611–617.

60. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol. 1996. 16:978–983.

61. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H. Advanced glycation endproducts accele- rate calcification in micro-vascular pericytes. Biochem Biophys Res Commun. 1999. 258:353–357.

62. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998. 280:605–613.

63. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002. 288:321–333.

64. Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA. Estrogen status correlates with the calcium content of coronary athero-sclerotic plaques in women. J Clin Endocrinol Metab. 2002. 87:1062–1067.